24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Cystic Fibrosis
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:47
From promised returns to financial distress: Israeli investors hit by overseas real estate slump
15:31
Israel weighs U.S.-style tax break for high-tech entrepreneurs
15:13
American buyer pays $18 million for Tel Aviv penthouse
14:46
Three years after October 7, Israeli reservists are still fighting to save their businesses
More stories
Buzz
Most popular
Daily
Weekly
1
Israel loses $1 billion Apache deal after failing to find $288 million in funding
2
U.S. Army deploys Elbit's Iron Fist defense system against missiles and drones
3
Flydubai passengers prepare lawsuits seeking hundreds of millions of dollars
4
Israeli startup raises $5 million to rethink one of surgery's most invasive procedures
5
“We had to accept reality”: At-Bay CEO on the $575 million Munich Re sale
More news
Cystic Fibrosis
1 stories about Cystic Fibrosis
SpliSense secures $28.5 million in funding to advance mRNA-altering pipeline for treatment of CF
13.05.21
|
Meir Orbach
The Israeli startup was founded by Prof. Batsheva Kerem, a renowned geneticist from the Hebrew University of Jerusalem, and its technology is based on her research